NEW YORK, Sept. 24 – Drug discovery and proteomics company Oxford GlycoSciences of Oxford, UK, said Monday its turnover for the first six months of the year totaled 8.7 million pounds ($12.7 million), compared with 4.5 million pounds in the year ago period. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.